![Christian Kanstrup](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Kanstrup
Directeur/Bestuurslid bij
NNIT A/S
Vermogen: 65 619 $ op 31-05-2026
Profiel
Christian Kanstrup is currently Chief Executive Officer at CKC ApS and Mr. Kanstrup Holding ApS, Chairman at Mediq Holding Danmark ApS, Independent Director at NNIT A since 2018, Director at Novo Nordisk Haemophilia Foundation, and Independent Director at Sleep Cycle AB starting in 2025.
Former roles include Chief Executive Officer at Evaxion AS from 2023 to 2025, Director at FastPassCorp A in 2019, Director at Glycom A, and SVP-Strategy, Access & Marketing at Novo Nordisk A from 2016 to 2017.
Education includes graduate degrees from the University of Copenhagen and the International Institute for Management Development.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SLEEP CYCLE AB 0,09% | 12-03-2026 | 17.500 ( 0,09% ) | 46 530 $ | 31-05-2026 |
NNIT A/S 0,01% | 31-12-2025 | 3.000 ( 0,01% ) | 19 089 $ | 31-05-2026 |
Actieve functies van Christian Kanstrup
| Bedrijven | Functie | Begin |
|---|---|---|
| NNIT A/S | Directeur/Bestuurslid | 08-03-2018 |
| SLEEP CYCLE AB | Directeur/Bestuurslid | 28-10-2025 |
Novo Nordisk Haemophilia Foundation | Directeur/Bestuurslid | - |
Mediq Holding Danmark ApS
 Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Voorzitter | - |
Christian Kanstrup Holding ApS | Algemeen Directeur | - |
CKC ApS | Algemeen Directeur | - |
Eerdere bekende functies van Christian Kanstrup
| Bedrijven | Functie | Einde |
|---|---|---|
| EVAXION A/S | Algemeen Directeur | 01-07-2025 |
| FASTPASSCORP A/S | Directeur/Bestuurslid | 02-03-2019 |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Directeur/Bestuurslid | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Christian Kanstrup
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
7
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
FastPassCorp A/S
 FastPassCorp A/S Information Technology ServicesTechnology Services Provides password management solutions, account unlock, and mapping services | Technology Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
 International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
NNIT A/S
 NNIT A/S Information Technology ServicesTechnology Services Provides digital transformation solutions to international life sciences companies | Technology Services |
Novo Nordisk Haemophilia Foundation | |
Evaxion Biotech A/S
 Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
CKC ApS | |
Christian Kanstrup Holding ApS | |
Sleep Cycle AB
 Sleep Cycle AB Packaged SoftwareTechnology Services Develops sleep applications and tools for tracking and analyzing sleep habits | Technology Services |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
